IOBT
IO Biotech·NASDAQ
--
--(--)
--
--(--)
3.83 / 10
Netural
Fund-flow data show a positive trend (score 7.67/10) with inflow ratios above 0.5 across block, small, medium, large, and extra-large categories, indicating broad buying interest despite recent volatility. Analyst coverage is thin (only one active analyst, neutral stance) and sentiment is neutral, but the combination of constructive money flow and limited bearish analyst input provides a supportive backdrop for potential rebound trades.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-26
InstitutionPiper Sandler
Times predicted2
Historical Win Rate0.0%
What is the market sentiment for IOBT?
- IOBT holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.83/10 (Netural).
